A clinician-guided decision
Zepbound activates GIP and GLP-1 hormone receptors, pathways involved in appetite and metabolism. A prescription decision should account for your health history, goals, current medicines, and whether medication is clinically appropriate.
What Zepbound is used for
Zepbound is used with a reduced-calorie eating plan and increased physical activity to help eligible adults reduce excess body weight and maintain weight reduction over time. It is also approved for certain adults with obesity and moderate-to-severe obstructive sleep apnea.
A clinician looks beyond a number on the scale. Your medical history, weight-related conditions, previous treatment, daily routine, and ability to follow up all help determine whether Zepbound may be a sensible option.
How treatment begins
Zepbound is injected under the skin once a week. Treatment commonly starts at 2.5 mg once weekly for four weeks. From there, a prescriber may increase the dose in steps, with at least four weeks between increases, based on response and tolerability.
The starting dose is designed to help your body adjust. It is not a race to the highest dose, and you should not change your dose or dosing schedule without guidance from the clinician who prescribed it.
What follow-up care should cover
Follow-up is where a treatment plan becomes personal. Resolve can review how you are feeling, whether you are able to eat and drink comfortably, changes in hunger or weight, and how the medication fits with your nutrition, activity, sleep, and other health needs.
If Zepbound is not the right fit because of side effects, health history, cost, or lack of benefit, that is useful information. A clinician can help you decide on the appropriate next step rather than leaving you to manage a medication change alone.
Side effects and important safety conversations
Common side effects can include nausea, diarrhea, vomiting, constipation, stomach discomfort, indigestion, injection-site reactions, fatigue, burping, hair loss, and reflux. Tell your prescribing clinician if symptoms are persistent, worsening, or make it difficult to eat or drink enough.
Before treatment begins, discuss your personal and family health history, especially medullary thyroid cancer or MEN 2, serious allergic reactions, severe stomach problems, pancreas or gallbladder concerns, kidney concerns, diabetes medicines, and pregnancy plans. Zepbound should not be used with another tirzepatide-containing medicine or another GLP-1 receptor agonist.
Medication and coverage questions
Bring a complete list of prescriptions, over-the-counter medicines, vitamins, and supplements to your visit. Zepbound can affect how quickly the stomach empties, which may affect some oral medicines. Oral hormonal birth control requires a specific conversation around starting treatment and dose increases.
Insurance coverage and manufacturer savings eligibility vary. Resolve can help you understand how insurance verification works and discuss the practical cost questions that matter before you commit to a plan.
Questions about insurance coverage? How we verify coverage
For further independent medication information, visit Zepbound resources.